Weak associations between human leucocyte antigen genotype and acute myocardial infarction

Journal of Internal Medicine

Volumn 268, Issue 1, 2010, Pages 50-58

  Bjorkbacka H ^a   Lavant, E H ^a,b   Fredrikson, G N ^a,b   Melander, O ^a   Berglund, G ^a   Carlson, J A ^a   Nilsson, J ^a  

^a LUND UNIVERSITY   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

Acute myocardial infarction; Atherosclerosis; Autoimmunity; Immunology

Indexed keywords

LEUKOCYTE ANTIGEN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; EPIDEMIOLOGIC METHODS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION;

EID: 77952539046     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02209.x     Document Type: Article

References (30)

1. Binder CJ, Chang MK, Shaw PX et al. Innate and acquired immunity in atherogenesis. Nat Med 2002 8 : 1218 1226.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352 : 1685 1695.
3. Nilsson J, Hansson GK. Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med 2008 263 : 464 478.
4. Palinski W, Witztum JL. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 2000 247 : 371 380.
5. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001 21 : 1876 1890.
6. Bjorkbacka H, Kunjathoor VV, Moore KJ et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004 10 : 416 421.
7. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1995 92 : 3893 3897.
8. Hulthe J. Antibodies to oxidized LDL in atherosclerosis development - clinical and animal studies. Clin Chim Acta 2004 348 : 1 8.
9. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 6 : 508 519.
10. Shah PK, Chyu KY, Fredrikson GN, Nilsson J. Immunomodulation of atherosclerosis with a vaccine. Nat Clin Pract Cardiovasc Med 2005 2 : 639 646.
11. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol 2005 14 : 175 182.
12. Fernando MM, Stevens CR, Walsh EC et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008 4 : e1000024.
13. Swanberg M, Lidman O, Padyukov L et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005 37 : 486 494.
14. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005 435 : 590 597.
15. Horton R, Wilming L, Rand V et al. Gene map of the extended human MHC. Nat Rev Genet 2004 5 : 889 899.
16. Porto I, Leone AM, Crea F, Andreotti F. Inflammation, genetics, and ischemic heart disease: focus on the major histocompatibility complex (MHC) genes. Cytokine 2005 29 : 187 196.
17. Palikhe A, Sinisalo J, Seppanen M, Valtonen V, Nieminen MS, Lokki ML. Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease. Tissue Antigens 2007 69 : 47 55.
18. Berglund G, Elmståhl S, Janzon L, Larsson S. The Malmö Diet Cancer Study: design and feasibility. J Intern Med 1993 233 : 43 51.
19. Manjer J, Carlsson S, Elmstahl S et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001 10 : 489 499.
20. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996 17 : 323 329.
21. Tsao BP. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004 16 : 513 521.
22. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989 36 : 178 182.
23. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987 30 : 1205 1213.
24. Erlich H, Valdes AM, Noble J et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008 57 : 1084 1092.
25. Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum Immunol 2003 64 : 930 935.
26. Park MH, Park YJ, Song EY et al. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol 2005 66 : 741 747.
27. Frostegård J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992 12 : 461 467.
28. Fredrikson GN, Hedblad B, Berglund G et al. Identification of immune responses against aldehyde-modified peptide sequences in apo B-100 associated with cardiovascular disease. Arterioscler Thromb Vasc Biol 2003 23 : 872 878.
29. Samani NJ, Erdmann J, Hall AS et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007 357 : 443 453. (Pubitemid 47204873)
30. Kathiresan S, Voight BF, Purcell S et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009 41 : 334 341.